Cytek Biosciences, Inc. CTKB
NASDAQ · United States · Health Technology
$5.87+0.06 (+0.95%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.09 | -0.09 | +3.6% | $48.14M | +1.8% | -2.8%$4.28→$4.16 |
| Q1 2026 | 2026-05-07 | -0.15 | -0.11 | -36.4% | — | — | -6.7% |
| Q4 2025 | 2026-02-26 | -0.04 | -0.04 | 0.0% | — | — | +2.5%$4.37→$4.48 |
| Q3 2025 | 2025-11-05 | -0.04 | -0.05 | +20.0% | — | — | +16.1%$3.91→$4.54 |
| Q4 2023 | 2024-03-13 | 0.08 | 0.04 | +100.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.